• Investigation of therapeutically exploitable targets involved in the regulation of BRMS1
  • Development of the first BRMS1 knockout murine model
  • Characterization of a novel variant of BRMS1 and its involvement in lung cancer
  • Characterizing the role of the adenosine deaminase acting on RNA (ADAR) gene as a potential oncogene in lung cancer
  • Investigation of a SNP in a previously uncharacterized transcript variant of BRMS1 and its association with disease aggressiveness